Introduction: Castleman disease is a lymphoproliferative process first described by Dr Benjamin Castleman in 1956. It has been reported to occur in various sites; however, accessory splenic involvement has only been reported once before. Clinically, it is divided into a solitary and a multicentric form. About 90% of the solitary forms are of the hyaline-vascular type, which shows enlarged follicles with tight concentric layering of lymphocytes, vascular proliferation within the follicles with central perivascular hyalinization. The interfollicular parenchymal usually shows prominent vascular proliferation admixed with a mixed inflammatory cell population. Our aim is to report a unique case of unicentric hyaline-vascular type Castleman disease involving a retroperitoneal accessory spleen that presented in an otherwise healthy woman. Method: This is a retrospective review of a case of a 32-year-old woman who presented with a retroperitoneal mass incidentally discovered on an abdominal ultrasound. Results: Radiographic studies showed a 6 cm contrast enhancing mass posterior to the pancreas clinically suspicious for malignancy. Fine needle aspirations failed to provide diagnostic material and the mass was surgically excised. The specimen showed a mixture of red and white pulp typical of splenic tissue. Enlarged follicles with concentric tight layering of small lymphocytes surrounding hyalinized central small blood vessels were present, as well as increased red pulp vascularity. Flow cytometry showed no evidence of a monoclonal lymphoid population. The findings were diagnostic of hyaline vascular type Castleman disease occurring in accessory splenic tissue. Conclusion: Unicentric Castleman disease usually acts in a benign fashion but can present in a variety of unusual sites including accessory splenic tissue and can be clinically confused with malignancy. Excisional biopsy is the procedure of choice for accurate diagnosis. . Eight-color peripheral blood flow cytometry revealed 56% blasts that were positive for CD7, CD34 (minor subset), CD33 (minor subset), CD56, CD117, CD41, and CD42b, consistent with a megakaryoblastic lineage. Peripheral blood karyotype, on presentation, revealed 47,XX+21[44]/46XX[6] mosaicism. FISH performed on the presenting peripheral blood revealed 101 cells with three copies of the21q22.13->22.2 region, consistent with trisomy 21. In addition, 58 cells were found to have four to six copies of the 21q22.13->22.2 region, and 41 cells were found to have two normal copies. After two weeks, the WBC count normalized with no evidence of blasts. Whole blood and saliva CombiSNP Array, one month after birth, revealed a normal female genomic profile with no diagnostic copy number changes. Unfortunately, fetal and placental hydrops fetalis with superimposed Pseudomonas aeruginosa infection of the lungs led to sepsis and patient expiration. Discussion: This is a unique presentation of TAM in a slightly phenotypically dysmorphic 46,XX female patient. This case most likely represents trisomy 21 mosaicism with associated TAM, an uncommon, but well documented presentation. The other less likely possibility is a constitutionally normal 46,XX karyotype with somatic trisomy 21 of the megakaryoblastic cells. The subpopulation of cultured peripheral blood cells showing four to six copies of chromosome 21 could represent a true somatic chromosomal aberration, but polyploidy is not an uncommon finding in cell cultures.
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A Rare Case of Small B-Cell Neoplasm in the Background of Lymphoplasmacytic Lymphoma
Amit Reddy, MBBS, Teja Poosarla, MD, Jaswinder Kaur, MD, John Lam, MD, Elizabeth Chastain, MD; University of Mississippi Medical Center, Jackson Waldenström macroglobulinemia (WM) is an IgMsecreting lymphoplasmacytic lymphoma (LPL). Other B-cell neoplasms, especially chronic myeloid leukemia and marginal zone lymphoma, show morphologic, clinical, and immunophenotypic overlap with LPL. We report a case of a 68-year-old man on immunosuppressive therapy after renal transplantation presenting
